SUPRIYA LIFESCIENCE LTD
SUPRIYA · General/Diversified · NSE
₹644
Current Market Price
Fair Value (DCF)
₹505
Margin of Safety
-21.6%
Updated 2h ago
YieldIQ Score
75/100
Piotroski F-Score
8/9
Economic Moat
Wide
Confidence
44%
ROE
—
Debt/Equity
0.00
WACC
11.1%
Market Cap
₹5,183 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
—
Return on capital employed
EV / EBITDA
19.4×
Enterprise multiple
Debt / EBITDA
0.0×
Leverage vs earnings
Interest Coverage
—
EBIT covers interest
Current Ratio
—
Short-term liquidity
Asset Turnover
0.61×
Revenue per ₹ of assets
Revenue CAGR (3Y)
9.4%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹643.95
Bear case
₹276.01
MoS -133.3%
Base case
₹504.58
MoS -27.6%
Bull case
₹563.69
MoS -14.2%
Ratio Trends
SUPRIYA · last 4 annual periods
ROE
18.9%
ROCE
26.9%
Operating Margin
—
Debt / Equity
0.01×
PE
40.2×
EV / EBITDA
10.7×
Historical Financials
SUPRIYA · Annual, last 4 years· amounts in ₹Cr unless noted
| Metric | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | ₹530 Cr | ₹451 Cr | ₹557 Cr | ₹680 Cr | +8.6% |
| EBITDA | ₹220 Cr | ₹137 Cr | ₹185 Cr | ₹269 Cr | +7.0% |
| EBIT | ₹211 Cr | ₹54.0 Cr | ₹53.8 Cr | — | -36.6% |
| PAT | ₹152 Cr | ₹89.9 Cr | ₹119 Cr | ₹188 Cr | +7.4% |
| EPS (diluted) | ₹18.86 | ₹4.75 | ₹4.59 | — | -37.6% |
| CFO | ₹48.8 Cr | ₹66.2 Cr | ₹113 Cr | ₹165 Cr | +50.0% |
| CapEx | — | — | — | ₹-162 Cr | — |
| FCF | — | — | — | ₹2.3 Cr | +0.0% |
| Total Assets | ₹735 Cr | ₹820 Cr | ₹921 Cr | ₹1112 Cr | +14.8% |
| Total Debt | — | ₹16.6 Cr | ₹0.0 Cr | ₹5.4 Cr | -31.3% |
| Shareholders' Equity | — | ₹699 Cr | ₹815 Cr | ₹997 Cr | +12.5% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
SUPRIYA vs 3 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| BLUEJET BLUEJET | — | — | Pending | 26.9% | — |
| CONCORDBIO CONCORDBIO | — | — | Pending | 20.5% | — |
| ONESOURCE ONESOURCE | — | — | Pending | -0.3% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for SUPRIYA in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. SUPRIYA LIFESCIENCE LTD (SUPRIYA.NS) trades at 643.95 vs a model fair value of 504.58, a gap of -21.6%. Piotroski F-score: 8/9. Moat labe...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of SUPRIYA →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for SUPRIYA →
Compare
Head-to-head with peers
Compare SUPRIYA side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse SUPRIYANow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.